EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Three‐Objects‐Three‐Places Episodic Memory Test to Screen Mild Cognitive Impairment and Mild Dementia: Validation in a Memory Clinic Population

Federica Ribaldi iD, Sophie Krug, Daniele Altomare, Valentina Garibotto, Max Scheffler, Augusto J Mendes, Aurelien Lathuiliere, Frederic Assal, Aldara Vazquez Fernandez, Stefano F Cappa iD, Christian Chicherio, Giovanni B Frisoni

European Journal of Neurology · 2025

DOI: 10.1111/ene.70074 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Federica Ribaldi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Memory, Episodic, Neuropsychological Tests, Dementia. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The projects of the Centre de la mémoire are funded by the State of Geneva and the following private donors under the supervision of the Private Foundation of…, A.P.R.A. - Association Suisse pour la Recherche sur la Maladie d'Alzheimer, Fondation Segré.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Three‐Objects‐Three‐Places (3O3P) test is a 5‐min screen for episodic memory impairment due to Alzheimer's disease, known for its briefness and easy administration, culture‐ and language‐free nature, and the absence of specific equipment. However, no studies have validated its potential in memory clinic cohorts. The aim of this study was to test its convergent, discriminant, and known‐group validities and to define thresholds for its clinical use.

Methods

We included 2062 cognitively unimpaired (CU), mild cognitive impairment (MCI) and dementia patients from the Geneva Memory Center cohort who underwent the 3O3P test in the context of clinical practice. Convergent and discriminant validities were assessed using an exploratory factor analysis. The known‐group validity was assessed in CU vs. MCI and dementia using the area under the curve (AUC). 3O3P test scores vs. amyloid and tau positivity, neurodegeneration, and cognition (ATNC) were assessed using the Kruskal‐Wallis test. The 3O3P test cut‐offs were calculated using sensitivity, specificity, PPV, NPV, and accuracy.

Results

Mean age was 72 years (SD = 11), 60% were female, mean education was 13 years (SD = 4), and mean MMSE was 25 (SD = 5). The 3O3P and Delayed Total Recall tests loaded strongly on the “memory” factor and weakly on “non‐memory” factors. The 3O3P test can discriminate CU vs. MCI (AUC = 0.71) and dementia (AUC = 0.92). Higher 3O3P scores were associated with lower prevalence of ATNC ( p < 0.001). A 3O3P value of 7 can detect MCI and dementia patients.

Conclusions

The 3O3P test has demonstrated good convergent, discriminant, and known‐group validity in a large memory clinic population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionMemory, EpisodicNeuropsychological TestsDementiaHumansFemaleAgedMaleAged, 80 and overMiddle AgedCohort StudiesReproducibility of Results

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkersdementiaepisodic memorymild cognitive impairment

Autor:innen und Institutionen

  • Geneva Memory Center, Department of Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
  • Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
  • Competence Centre on Ageing (CCA) Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Manno, Switzerland.
  • Laboratory of Neuroimaging and Innovative Molecular Tracers (NIMTlab), Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals, Geneva, Switzerland.
  • CIBM Center for Biomedical Imaging, Geneva, Switzerland.

ORCID-Profile: Federica Ribaldi, Stefano F Cappa

Förderung

  • The projects of the Centre de la mémoire are funded by the State of Geneva and the following private donors under the supervision of the Private Foundation of…
  • A.P.R.A. - Association Suisse pour la Recherche sur la Maladie d'Alzheimer
  • Fondation Segré
  • Race Against Dementia Foundation
  • Fondation Child Care
  • Fondation Edmond J. Safra
  • Fondation Minkoff
  • Fondazione Agusta,

Zitieren

APA

Ribaldi, F., Krug, S., Altomare, D., Garibotto, V., Scheffler, M., Mendes, A. J., Lathuiliere, A., Assal, F., Fernandez, A. V., Cappa, S. F., Chicherio, C., & Frisoni, G. B. (2025). Three‐Objects‐Three‐Places Episodic Memory Test to Screen Mild Cognitive Impairment and Mild Dementia: Validation in a Memory Clinic Population. European Journal of Neurology. https://doi.org/10.1111/ene.70074

Vancouver

Ribaldi F, Krug S, Altomare D, Garibotto V, Scheffler M, Mendes AJ, et al. Three‐Objects‐Three‐Places Episodic Memory Test to Screen Mild Cognitive Impairment and Mild Dementia: Validation in a Memory Clinic Population. European Journal of Neurology. 2025. doi:10.1111/ene.70074

BibTeX
@article{Ribaldi2025,
  author = {Ribaldi, Federica and Krug, Sophie and Altomare, Daniele and Garibotto, Valentina and Scheffler, Max and Mendes, Augusto J and Lathuiliere, Aurelien and Assal, Frederic and Fernandez, Aldara Vazquez and Cappa, Stefano F and Chicherio, Christian and Frisoni, Giovanni B},
  title = {Three‐Objects‐Three‐Places Episodic Memory Test to Screen Mild Cognitive Impairment and Mild Dementia: Validation in a Memory Clinic Population},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70074}
}
Kostenlos starten →